insights_auto
Mengapa 688235 naik 4,06%?
Pelajari Lebih Lanjutchevron_right
688235:SHA
BeOne Medicines AG
CNÂ¥255,98
arrow_upward
+4,06%(+9,99) 1 HR
16 Okt, 15.00.00 GMT+8 · CNY
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk 688235...
Pembukaan
CNÂ¥253,20
Tinggi
CNÂ¥268,18
Rendah
CNÂ¥252,09
Kapitalisasi pasar
289,03Â M
Volume rata-rata
2,81Â jt
Volume
5,69Â jt
Rasio P/E
91,43
Harga tinggi dalam 52 minggu terakhir
CNÂ¥319,24
Harga rendah dalam 52 minggu terakhir
CNÂ¥205,51
EPS
CNÂ¥2,80
Jumlah karyawan
12Â rb
Pembukaan
CNÂ¥253,20
Tinggi
CNÂ¥268,18
Rendah
CNÂ¥252,09
Kapitalisasi pasar
289,03Â M
Volume rata-rata
2,81Â jt
Volume
5,69Â jt
Rasio P/E
91,43
Harga tinggi dalam 52 minggu terakhir
CNÂ¥319,24
Harga rendah dalam 52 minggu terakhir
CNÂ¥205,51
EPS
CNÂ¥2,80
Jumlah karyawan
12Â rb
Artikel berita
Dari sumber web dan partner berita
MarketBeat
·
9 jam yang lalu
TB Alternative Assets Ltd. Makes New $5.42 Million Investment in BeOne Medicines Ltd. - Sponsored ADR $ONC
Liputan6.com
·
20 jam yang lalu
Tanpa Gelar Dokter, Pria Ini Cetak Kekayaan Rp 37 Triliun dari Bisnis Obat
Stock Titan
·
22 jam yang lalu
Under a preset trading plan, BeOne Medicines (ONC) director sells 31,027 depositary shares.
Profil
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the company is headquartered in Cambridge, Massachusetts and has locations on six continents, in over 45 countries. BeOne has a large presence in the Chinese market.
BeOne Medicines has developed several medicines, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. On 14 November 2024, the company announced its intention to rebrand as BeOne Medicines. BeOne changed its stock ticker to ONC in January 2025 and redomiciled to Basel, Switzerland in May 2025. Wikipedia
Tentang BeOne Medicines AG
CEOJohn Vincent Oyler | John Vincent Oyler
Karyawan12Â rb
Didirikan28 Okt 2010
Kantor Pusat-
Sektor-
Situsbeonemedicines.com